Detailed dose evidence documented for Sermorelin in its monograph — reference only, not dosing recommendations.
Reference only — not a dosing recommendation.
Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
Historical US labeling described a Geref pediatric treatment regimen of 30 mcg/kg subcutaneously at bedtime and a distinct Geref Diagnostic exposure of 1 mcg/kg intravenously. These are archived, product-specific label facts for discontinued products, not current prescribing recommendations.
Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
No established or recommended human dose. Compounded adult “anti-aging” regimens are market practice rather than an FDA-reviewed dose and are not reproduced here.
Not established
What is not established
No adequate human trials exist for body composition, frailty, cognitive, or sports recovery claims. The optimal adult dose, treatment duration, and long-term safety profile are not established.